Pay in 4 interest-free payments of $5.97 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Advancements In GLP-1 Agonist Therapies For Diabetes And Weight Management GLP-1 agonists and glucose-dependent insulinotropic polypeptide (GIP) agonists mimic naturally occurring incretin hormones to slow gastric emptying, increase the feeling of fullness, promote insulin secretion, and inhibit the inappropriate release of glucagon
These mechanisms plausibly influence behavioral domains (irritability, hyperactivity, sociability, language, sleep) and interact with gastrointestinal comorbidities and barrier integrity
Sanz-Rodrguez E, et al
A genetic mechanism for Tibetan high-altitude adaptation
(2024, November 26)
US$ 28.63
US$ 23.27
US$ 24.93
